Cargando…
Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1
Adoptive transfer of tumor-specific cytotoxic T cells is a promising advance in cancer therapy. Similarly, checkpoint inhibition has shown striking clinical results in some patients. Here we combine adoptive cell transfer with ablation of the checkpoint protein Src homology 2-domain-containing phosp...
Autores principales: | Watson, H Angharad, Dolton, Garry, Ohme, Julia, Ladell, Kristin, Vigar, Miriam, Wehenkel, Sophie, Hindley, James, Mohammed, Rebar N, Miners, Kelly, Luckwell, Rhys A, Price, David A, Matthews, R James, Ager, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027373/ https://www.ncbi.nlm.nih.gov/pubmed/27430370 http://dx.doi.org/10.1038/icb.2016.45 |
Ejemplares similares
-
SHP-1: the next checkpoint target for cancer immunotherapy?
por: Watson, H. Angharad, et al.
Publicado: (2016) -
L-selectin Is Essential for Delivery of Activated CD8(+) T Cells to Virus-Infected Organs for Protective Immunity
por: Mohammed, Rebar N., et al.
Publicado: (2016) -
ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells
por: Mohammed, Rebar N., et al.
Publicado: (2019) -
Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
por: Ager, Ann, et al.
Publicado: (2016) -
L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy
por: Watson, H. Angharad, et al.
Publicado: (2019)